CVE-2025-27955Clinical Collaboration Platform 12.2.1.5 has a weak logout system where the session token remains valid after logout and allows a remote attacker to obtain sensitive information and execute arbitrary…
Updated under an hour ago ()
Does this affect you?
It affects philips clinical_collaboration_platform. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.34%, higher than 27% of scored CVEs.
Do this next
Free account, 1 product
Clinical Collaboration Platform 12.2.1.5 has a weak logout system where the session token remains valid after logout and allows a remote attacker to obtain sensitive information and execute arbitrary code.
- CVSS
- 6.5 MEDIUM (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
- Weakness (CWE)
- CWE-1259
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.34% (percentile 27)
- Assigned by
- mitre
- NVD analysis
- Analyzed
- Record last updated
- Jun 11, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
philips clinical_collaboration_platform philips:clinical_collaboration_platform | 12.2.1.5 | NVD |
References
- https://github.com/intruderlabs/cvex/tree/main/Carestream/session-token-in-urlthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.